Türk Beyin Damar Hast Derg. 2019; 25(2): 86-93 | DOI: 10.5505/tbdhd.2019.58561

Dual antiplatelet therapy in ischemic stroke

Birsen Ýnce
Istanbul University-Cerrahpaþa Medical Faculty, Department of Neurology, Division of Cerebrovascular Disease, Istanbul, Turkey

Antiplatelet drugs are widely used for secondary prophylaxis of ischemic stroke. Antiplatelet therapy can significantly reduce the risk of vascular events among high-risk patients. This review highlights the improvements of the use of dual antiplatelet therapy, particularly aspirin and clopidogrel combination, for the prevention of non-cardioembolic ischemic stroke.

Keywords: ischemic stroke, dual antiplatelet, therapy

---

Ýskemik inmede ikili antiagregan tedavi

Birsen Ýnce
Ýstanbul Üniversitesi-Cerrahpaþa Týp Fakültesi, Nöroloji Anabilim Dalý, Beyin Damar Hastalýklarý Bilim Dalý, Ýstanbul

Antiagregan ilaçlar iskemik inmenin sekonder proflaksisinde yaygýn olarak kullanýlýrlar. Antiagregan tedavi yüksek riskli hastalarda vasküler bir olay geliþme riskini anlamlý ölçüde azaltabilir. Bu derlemede kardiyoembolik olmayan iskemik inmenin önlenmesinde ikili antiagregan tedavi, özellikle aspirin ve klopidogrel kombinasyonunun kullanýmý ile ilgili geliþmeler vurgulanmaktadýr.

Anahtar Kelimeler: iskemik inme, ikili antiagregan, tedavi

---

CITE